Display options
Cite
Ferdinandusse S, McWalter K, Te Brinke H, et al. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids. Genet Med. 2021;23(12):2467doi: 10.1038/s41436-021-01189-8.
Ferdinandusse, S., McWalter, K., Te Brinke, H., IJlst, L., Mooijer, P. M., Ruiter, J. P. N., van Lint, A. E. M., Pras-Raves, M., Wever, E., Millan, F., Guillen Sacoto, M. J., Begtrup, A., Tarnopolsky, M., Brady, L., Ladda, R. L., Sell, S. L., Nowak, C. B., Douglas, J., Tian, C., Ulm, E., Perlman, S., Drack, A. V., Chong, K., Martin, N., Brault, J., Brokamp, E., Toro, C., Gahl, W. A., Macnamara, E. F., Wolfe, L., Waisfisz, Q., Zwijnenburg, P. J. G., Ziegler, A., Barth, M., Smith, R., Ellingwood, S., Gaebler-Spira, D., Bakhtiari, S., Kruer, M. C., van Kampen, A. H. C., Wanders, R. J. A., Waterham, H. R., Cassiman, D., & Vaz, F. M. (2021). Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids. Genetics in medicine : official journal of the American College of Medical Genetics, 23(12), 2467. https://doi.org/10.1038/s41436-021-01189-8
Ferdinandusse, Sacha, et al. "Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids." Genetics in medicine : official journal of the American College of Medical Genetics vol. 23,12 (2021): 2467. doi: https://doi.org/10.1038/s41436-021-01189-8
Ferdinandusse S, McWalter K, Te Brinke H, IJlst L, Mooijer PM, Ruiter JPN, van Lint AEM, Pras-Raves M, Wever E, Millan F, Guillen Sacoto MJ, Begtrup A, Tarnopolsky M, Brady L, Ladda RL, Sell SL, Nowak CB, Douglas J, Tian C, Ulm E, Perlman S, Drack AV, Chong K, Martin N, Brault J, Brokamp E, Toro C, Gahl WA, Macnamara EF, Wolfe L, Waisfisz Q, Zwijnenburg PJG, Ziegler A, Barth M, Smith R, Ellingwood S, Gaebler-Spira D, Bakhtiari S, Kruer MC, van Kampen AHC, Wanders RJA, Waterham HR, Cassiman D, Vaz FM. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids. Genet Med. 2021 Dec;23(12):2467. doi: 10.1038/s41436-021-01189-8. PMID: 34667295; PMCID: PMC8629751.
Copy Download .nbib Format: NLM
Share it on

Genet Med. 2021 Dec;23(12):2467. doi: 10.1038/s41436-021-01189-8.

Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.

Genetics in medicine : official journal of the American College of Medical Genetics

Sacha Ferdinandusse, Kirsty McWalter, Heleen Te Brinke, Lodewijk IJlst, Petra M Mooijer, Jos P N Ruiter, Alida E M van Lint, Mia Pras-Raves, Eric Wever, Francisca Millan, Maria J Guillen Sacoto, Amber Begtrup, Mark Tarnopolsky, Lauren Brady, Roger L Ladda, Susan L Sell, Catherine B Nowak, Jessica Douglas, Cuixia Tian, Elizabeth Ulm, Seth Perlman, Arlene V Drack, Karen Chong, Nicole Martin, Jennifer Brault, Elly Brokamp, Camilo Toro, William A Gahl, Ellen F Macnamara, Lynne Wolfe, Quinten Waisfisz, Petra J G Zwijnenburg, Alban Ziegler, Magalie Barth, Rosemarie Smith, Sara Ellingwood, Deborah Gaebler-Spira, Somayeh Bakhtiari, Michael C Kruer, Antoine H C van Kampen, Ronald J A Wanders, Hans R Waterham, David Cassiman, Frédéric M Vaz

Affiliations

  1. Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands. [email protected].
  2. GeneDx, Gaithersburg, MD, USA.
  3. Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
  4. Core Facility Metabolomics, Amsterdam UMC, Amsterdam, The Netherlands.
  5. Bioinformatics Laboratory, Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  6. Department of Pediatrics, McMaster University Children's Hospital, Hamilton, ON, Canada.
  7. Department of Pediatrics, Penn State Children's Hospital, Hershey, PA, USA.
  8. The Feingold Center for Children, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  9. Division of Neurology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  10. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  11. Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  12. Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.
  13. Mount Sinai Hospital, Department of Obstetrics and Gynecology, Prenatal Diagnosis and Medical Genetics Program, Toronto, ON, Canada.
  14. Vanderbilt University Medical Center, Department of Pediatrics, Nashville, TN, USA.
  15. NIH Undiagnosed Diseases Program, Office of the Clinical Director, National Human Genome Research Institute, NIH, Bethesda, MD, USA.
  16. Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  17. Genetic department, University Hospital Angers, Angers, France.
  18. Division of Genetics, Department of Pediatrics, Maine Medical Center, Portland, ME, USA.
  19. Feinberg Northwestern University School of Medicine, Shirley Ryan Ability Lab, Chicago, IL, USA.
  20. Barrow Neurological Institute, Phoenix Children's Hospital and University of Arizona College of Medicine, Phoenix, AZ, USA.
  21. Biosystems Data Analysis, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
  22. Department of Gastroenterology-Hepatology, Metabolic Center, University Hospitals Leuven, Leuven, Belgium.
  23. Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands. [email protected].

PMID: 34667295 PMCID: PMC8629751 DOI: 10.1038/s41436-021-01189-8

[No abstract available.]

Publication Types